CTI BioPharma Net Profit Margin 2006-2020 | CTIC

CTI BioPharma net profit margin from 2006 to 2020. Net profit margin can be defined as net Income as a portion of total sales revenue.
CTI BioPharma Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2019-09-30 $0.02B $-0.03B -182.35%
2019-06-30 $0.02B $-0.04B -225.00%
2019-03-31 $0.02B $-0.04B -211.76%
2018-12-31 $0.03B $-0.03B -107.41%
2018-09-30 $0.01B $-0.04B -338.46%
2018-06-30 $0.01B $-0.04B -292.86%
2018-03-31 $0.04B $-0.03B -82.86%
2017-12-31 $0.03B $-0.05B -180.00%
2017-09-30 $0.03B $-0.04B -108.82%
2017-06-30 $0.04B $-0.05B -150.00%
2017-03-31 $0.02B $-0.08B -357.14%
2016-12-31 $0.06B $-0.05B -92.86%
2016-09-30 $0.06B $-0.08B -129.31%
2016-06-30 $0.06B $-0.08B -143.64%
2016-03-31 $0.05B $-0.09B -187.76%
2015-12-31 $0.02B $-0.12B -775.00%
2015-09-30 $0.02B $-0.14B -604.35%
2015-06-30 $0.06B $-0.10B -162.90%
2015-03-31 $0.06B $-0.10B -153.23%
2014-12-31 $0.06B $-0.10B -158.33%
2014-09-30 $0.08B $-0.04B -54.67%
2014-06-30 $0.04B $-0.07B -194.29%
2014-03-31 $0.03B $-0.06B -173.53%
2013-12-31 $0.03B $-0.05B -144.12%
2010-12-31 $0.00B $-0.15B inf%
2010-06-30 $0.00B $-0.17B inf%
2010-03-31 $0.00B $-0.15B inf%
2009-12-31 $0.00B $-0.12B inf%
2009-09-30 $0.00B $-0.13B -4333.33%
2009-06-30 $0.01B $-0.13B -2150.00%
2009-03-31 $0.01B $-0.16B -1788.89%
2008-12-31 $0.01B $-0.20B -1691.67%
2008-09-30 $0.01B $-0.20B -2233.33%
2008-06-30 $0.01B $-0.21B -3433.33%
2008-03-31 $0.00B $-0.18B -5833.33%
2007-12-31 $0.00B $-0.15B inf%
2007-09-30 $0.00B $-0.15B inf%
2007-06-30 $0.00B $-0.12B inf%
2007-03-31 $0.00B $-0.11B inf%
2006-12-31 $0.00B $-0.14B inf%
2006-09-30 $0.00B $-0.12B -11900.00%
2006-06-30 $0.00B $-0.10B -5000.00%
2006-03-31 $0.01B $-0.12B -1288.89%
2005-12-31 $0.02B $-0.10B -686.67%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.077B $0.003B
CTI BioPharma Corp. is a biopharmaceutical company. It is focused on the acquisition, development and commercialization of therapies covering a spectrum of blood-related cancers. The company is heavily focused on marketing its approved therapy Pixuvri in Europe, and on continuing the development of its late-stage development pipeline, including pacritinib. CTI BioPharma Corp., formerly known as Cell Therapeutics, Inc., is headquartered in Seattle, Washington.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $76.422B 43.47
Takeda Pharmaceutical (TAK) Japan $58.420B 10.18
Astellas Pharma (ALPMY) Japan $28.504B 0.00
Eisai (ESALY) Japan $26.706B 22.57
UCB SA (UCBJF) Belgium $22.660B 0.00
Merck (MKGAF) Germany $18.456B 0.00
Ono Pharmaceutical (OPHLF) Japan $15.737B 27.83
Catalent (CTLT) United States $13.487B 43.84
Grifols, S.A (GRFS) Spain $11.393B 13.92
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $11.140B 0.00
Neurocrine Biosciences (NBIX) United States $9.111B 35.27
IPSEN SA ADR (IPSEY) France $8.650B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $8.360B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.741B 12.81
STADA ARZNEIMI (STDAF) Germany $7.169B 0.00
Orion OYJ (ORINY) Finland $7.077B 24.56
Ionis Pharmaceuticals (IONS) United States $6.803B 43.10
Arrowhead Pharmaceuticals (ARWR) United States $4.594B 0.00
United Therapeutics (UTHR) United States $4.461B 10.31
Evotec AG (EVTCY) Germany $4.033B 140.00
FibroGen (FGEN) United States $3.819B 0.00
ChemoCentryx (CCXI) United States $3.633B 0.00
Hypermarcas (HYPMY) Brazil $3.496B 12.86
Sage Therapeutics (SAGE) United States $3.161B 0.00
PTC Therapeutics (PTCT) United States $3.155B 0.00
Nektar Therapeutics (NKTR) United States $3.150B 0.00
Pacira BioSciences (PCRX) United States $2.518B 66.19
Revolution Medicines (RVMD) United States $2.167B 0.00
Xencor (XNCR) United States $2.161B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.097B 10.15
Corcept Therapeutics (CORT) United States $1.975B 18.18
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.799B 0.00
Cronos Group (CRON) Canada $1.777B 0.00
USANA Health Sciences (USNA) United States $1.571B 14.80
Ironwood Pharmaceuticals (IRWD) United States $1.512B 10.50
Trillium Therapeutics (TRIL) Canada $1.345B 0.00
Heron Therapeutics (HRTX) United States $1.327B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.187B 11.31
Indivior (INVVY) United States $1.162B 14.40
Karyopharm Therapeutics (KPTI) United States $1.090B 0.00
Esperion Therapeutics (ESPR) United States $1.044B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.005B 0.00
CLINIGEN GP (CLIGF) United Kingdom $0.991B 0.00
Translate Bio (TBIO) United States $0.975B 0.00
Zogenix (ZGNX) United States $0.970B 0.00
Vectura Group (VEGPF) United Kingdom $0.894B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.877B 546.13
VAXART, INC (VXRT) United States $0.808B 0.00
Endo (ENDP) Ireland $0.753B 1.11
BioCryst Pharmaceuticals (BCRX) United States $0.643B 0.00
ImmunoGen (IMGN) United States $0.642B 0.00
Collegium Pharmaceutical (COLL) United States $0.638B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.627B 0.00
Tilray (TLRY) Canada $0.609B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.561B 0.00
Siga Technologies (SIGA) United States $0.550B 58.67
Flexion Therapeutics (FLXN) United States $0.543B 0.00
Molecular Templates (MTEM) United States $0.523B 0.00
Aerie Pharmaceuticals (AERI) United States $0.521B 0.00
Radius Health (RDUS) United States $0.509B 0.00
Ocular Therapeutix (OCUL) United States $0.497B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.484B 0.00
Ardelyx (ARDX) United States $0.480B 0.00
Altimmune (ALT) United States $0.425B 0.00
Organogenesis Holdings (ORGO) United States $0.396B 0.00
Harpoon Therapeutics (HARP) United States $0.389B 0.00
TherapeuticsMD (TXMD) United States $0.384B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.383B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.382B 19.03
Redhill Biopharma (RDHL) Israel $0.356B 0.00
Akebia Therapeutics (AKBA) United States $0.355B 0.00
DURECT (DRRX) United States $0.355B 0.00
MEI Pharma (MEIP) United States $0.351B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.327B 8.10
Innate Pharma SA (IPHYF) France $0.324B 0.00
PROFOUND MEDICL (PROF) Canada $0.324B 0.00
IMV INC (IMV) Canada $0.295B 0.00
Jounce Therapeutics (JNCE) United States $0.280B 13.27
Xeris Pharmaceuticals (XERS) United States $0.266B 0.00
Concert Pharmaceuticals (CNCE) United States $0.265B 0.00
Aquestive Therapeutics (AQST) United States $0.256B 0.00
Menlo Therapeutics (VYNE) United States $0.255B 0.00
Rafael Holdings (RFL) United States $0.255B 0.00
Calithera Biosciences (CALA) United States $0.237B 0.00
Lannett Co Inc (LCI) United States $0.236B 5.48
KalVista Pharmaceuticals (KALV) United States $0.231B 0.00
Nature's Sunshine Products (NATR) United States $0.218B 21.50
Avadel Pharmaceuticals (AVDL) Ireland $0.196B 0.00
Nivalis Therapeutics (ALPN) United States $0.195B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.194B 0.00
Heat Biologics (HTBX) United States $0.190B 0.00
CASI Pharmaceuticals (CASI) United States $0.188B 0.00
Otonomy (OTIC) United States $0.174B 0.00
OptiNose (OPTN) United States $0.172B 0.00
Taiwan Liposome (TLC) Taiwan $0.170B 0.00
Ayala Pharmaceuticals (AYLA) Israel $0.164B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.140B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.135B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.128B 0.00
Champions Oncology (CSBR) United States $0.119B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.110B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.107B 0.00
Aclaris Therapeutics (ACRS) United States $0.105B 0.00
MediWound (MDWD) Israel $0.101B 0.00
Lipocine (LPCN) United States $0.093B 0.00
Biomerica (BMRA) United States $0.083B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.076B 0.00
ElectroCore (ECOR) United States $0.072B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.071B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.071B 0.00
Novan (NOVN) United States $0.069B 0.00
Addex Therapeutics (ADXN) Switzerland $0.068B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.064B 0.00
Infinity Pharmaceuticals (INFI) United States $0.063B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.063B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.053B 0.00
Onconova Therapeutics (ONTX) United States $0.052B 0.00
KemPharm (KMPH) United States $0.051B 0.00
Natural Alternatives (NAII) United States $0.050B 0.00
CV Sciences (CVSI) United States $0.050B 0.00
Recro Pharma (REPH) United States $0.049B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.049B 29.36
SCYNEXIS (SCYX) United States $0.048B 0.00
ProPhase Labs (PRPH) United States $0.044B 0.00
Forward Pharma (FWP) Denmark $0.041B 0.00
PolarityTE (PTE) United States $0.040B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.038B 0.00
GTx (ONCT) United States $0.036B 0.00
Mannatechorporated (MTEX) United States $0.035B 8.96
Opiant Pharmaceuticals (OPNT) United States $0.033B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.033B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.030B 0.00
Neos Therapeutics (NEOS) United States $0.028B 0.00
Jaguar Animal Health (JAGX) United States $0.025B 0.00
Vical (BBI) United States $0.023B 0.00
Midatech Pharma (MTP) United Kingdom $0.022B 0.00
Sundial Growers (SNDL) Canada $0.019B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.018B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.017B 0.00
Regulus Therapeutics (RGLS) United States $0.017B 0.00
HANCOCK JAFFE (HJLI) United States $0.017B 0.00
Flex Pharma (SLRX) United States $0.016B 0.00
Cyanotech (CYAN) United States $0.016B 23.36
Bio-Path Holdings (BPTH) United States $0.015B 0.00
Iterum Therapeutics (ITRM) Ireland $0.014B 0.00
RXi Pharmaceuticals (PHIO) United States $0.013B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.011B 0.00
China SXT Pharmaceuticals (SXTC) China $0.009B 0.00
Shineco (TYHT) China $0.009B 0.00
JanOne (JAN) United States $0.009B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00